Pliant Therapeutics Inc (NASDAQ: PLRX): Stock That Needs Special Handling
Currently, there are 60.85M common shares owned by the public and among those 53.50M shares have been available to trade. The company’s stock has a 5-day price change of -77.09% and -82.85% over the past three months. PLRX shares are trading -80.22% year to date (YTD), with the 12-month market performance down to -84.01% lower. […]
Pliant Therapeutics Inc (PLRX) Testing Investors’ Patience Right Now
Currently, there are 60.85M common shares owned by the public and among those 53.50M shares have been available to trade. The company’s stock has a 5-day price change of -72.54% and -80.45% over the past three months. PLRX shares are trading -76.69% year to date (YTD), with the 12-month market performance down to -80.78% lower. […]
